JGP Global Gestao de Recursos’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,213
| Closed | -$347K | – | 42 |
|
|
2024
Q2 | $347K | Sell |
4,213
-12
| -0.3% | -$999 | 0.44% | 24 |
|
|
2024
Q1 | $369K | Buy |
4,225
+1,093
| +35% | +$97.8K | 0.24% | 28 |
|
|
2023
Q4 | $302K | Buy |
3,132
+419
| +15% | +$37.1K | 0.18% | 34 |
|
|
2023
Q3 | $240K | Hold |
2,713
| – | – | 0.15% | 42 |
|
|
2023
Q2 | $235K | Hold |
2,713
| – | – | 0.16% | 56 |
|
|
2023
Q1 | $264K | Hold |
2,713
| – | – | 0.27% | 40 |
|
|
2022
Q4 | $281K | Hold |
2,713
| – | – | 0.2% | 45 |
|
|
2022
Q3 | $230K | Hold |
2,713
| – | – | 0.19% | 46 |
|
|
2022
Q2 | $225K | Hold |
2,713
| – | – | 0.17% | 45 |
|
|
2022
Q1 | $209K | Sell |
2,713
-322
| -11% | -$26.9K | 0.12% | 57 |
|
|
2021
Q4 | $268K | Sell |
3,035
-1
| -0% | -$83 | 0.12% | 53 |
|
|
2021
Q3 | $235K | Sell |
3,036
-74
| -2% | -$5.84K | 0.09% | 66 |
|
|
2021
Q2 | $259K | Buy |
3,110
+1
| +0% | +$79 | 0.09% | 55 |
|
|
2021
Q1 | $235K | Sell |
3,109
-2,009
| -39% | -$164K | 0.15% | 47 |
|
|
2020
Q4 | $449K | Sell |
5,118
-166
| -3% | -$13.2K | 1.69% | 23 |
|
|
2020
Q3 | $402K | Sell |
5,284
-42
| -0.8% | -$4.25K | 0.22% | 36 |
|
|
2020
Q2 | $657K | Hold |
5,326
| – | – | 0.39% | 21 |
|
|
2020
Q1 | $450K | Sell |
5,326
-212
| -4% | -$18.3K | 0.2% | 34 |
|
|
2019
Q4 | $468K | Buy |
5,538
+60
| +1% | +$4.53K | 0.17% | 41 |
|
|
2019
Q3 | $369K | Buy |
5,478
+809
| +17% | +$62.3K | 0.2% | 44 |
|
|
2019
Q2 | $400K | Sell |
4,669
-8,650
| -65% | -$740K | 0.16% | 32 |
|
|
2019
Q1 | $1.18M | Buy |
13,319
+1,027
| +8% | +$95.2K | 0.44% | 15 |
|
|
2018
Q4 | $1.05M | Sell |
12,292
-4,531
| -27% | -$431K | 1.27% | 8 |
|
|
2018
Q3 | $1.63M | Buy |
+16,823
| New | +$1.68M | 2.76% | 9 |
|
|
2018
Q2 | – | Sell |
-18,506
| Closed | -$1.5M | – | 14 |
|
|
2018
Q1 | $1.5M | Buy |
18,506
+1,529
| +9% | +$131K | 0.6% | 7 |
|
|
2017
Q4 | $1.51M | Sell |
16,977
-1,529
| -8% | -$133K | 0.74% | 10 |
|
|
2017
Q3 | $1.72M | Sell |
18,506
-758
| -4% | -$67K | 1.77% | 12 |
|
|
2017
Q2 | $1.75M | Sell |
19,264
-2,360
| -11% | -$215K | 2.32% | 5 |
|
|
2017
Q1 | $1.9M | Buy |
21,624
+5,328
| +33% | +$474K | 1.58% | 6 |
|
|
2016
Q4 | $1.35M | Buy |
16,296
+5,848
| +56% | +$503K | 0.69% | 14 |
|
|
2016
Q3 | $967K | Buy |
10,448
+131
| +1% | +$12.3K | 0.09% | 17 |
|
|
2016
Q2 | $803K | Buy |
10,317
+2,860
| +38% | +$243K | 0.15% | 25 |
|
|
2016
Q1 | $615K | Buy |
+7,457
| New | +$607K | 0.26% | 28 |
|
Other funds holding BMRN
EIM
JGP Global Gestao de Recursos's BMRN Position: Q3 2024 in Review
JGP Global Gestao de Recursos sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2024, closing a stake of 4,213 shares — an estimated $347K sold.
JGP Global Gestao de Recursos first reported a position in BMRN in Q1 2016 and held it in 33 quarters. The position peaked at $1.9M in Q1 2017. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.
- JGP Global Gestao de Recursos reported no remaining BioMarin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- JGP Global Gestao de Recursos sold 4,213 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $347K.
- JGP Global Gestao de Recursos first reported a position in BioMarin Pharmaceuticals in Q1 2016 and held it in 33 quarters.
- JGP Global Gestao de Recursos's BioMarin Pharmaceuticals position peaked at $1.9M in Q1 2017.
- 553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.
Based on JGP Global Gestao de Recursos's 13F filing for Q3 2024, filed 1 Nov 2024.